Lung Cancer Screening: Who Pays? Who Receives?-the Chinese Perspective

Overview

Journal Transl Lung Cancer Res

Date 2021 Jun 24

PMID 34164286

Citations 6

Authors

Yang Zhang

Haiquan Chen

Affiliations

Soon will be listed here.

Abstract

The National Lung Screening Trial (NLST) revealed that low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20.0%. In China, LDCT is very cheap and easy to access. As a result, LDCT screening is not limited to "high-risk" population defined by the NLST trial. The results of LDCT screening in China are also quite different from that in Western countries. LDCT detected lung cancer in a significant proportion of young, female and non-smokers in China. There is also a higher proportion of adenocarcinoma (ADC), a lower proportion of squamous cell carcinoma, and a higher proportion of early-stage 0/I disease among LDCT-detected lung cancer in China. The issue of overdiagnosis and overtreatment is discussed. Finally, we call the global attention to clarify the etiology of lung cancer in young female non-smokers.

Citing Articles

Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation study.

Du Y, Li Y, Sidorenkov G, Vliegenthart R, Heuvelmans M, Dorrius M J Natl Cancer Cent. 2024; 2(1):18-24.

PMID: 39035210 PMC: 11256619. DOI: 10.1016/j.jncc.2021.11.002.

Long-term trends of lung cancer incidence and survival in southeastern China, 2011-2020: a population-based study.

Zhou Y, Xiang Z, Lin W, Lin J, Wen Y, Wu L BMC Pulm Med. 2024; 24(1):25.

PMID: 38200537 PMC: 10782768. DOI: 10.1186/s12890-024-02841-0.

Benign-malignant classification of pulmonary nodules by low-dose spiral computerized tomography and clinical data with machine learning in opportunistic screening.

Zheng Y, Dong J, Yang X, Shuai P, Li Y, Li H Cancer Med. 2023; 12(11):12050-12064.

PMID: 37248730 PMC: 10278478. DOI: 10.1002/cam4.5886.

See Lung Cancer with an AI.

Bidzinska J, Szurowska E Cancers (Basel). 2023; 15(4).

PMID: 36831662 PMC: 9954317. DOI: 10.3390/cancers15041321.

The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis.

Almatrafi A, Thomas O, Callister M, Gabe R, Beeken R, Neal R J Med Screen. 2022; 30(1):3-13.

PMID: 35942779 PMC: 9925896. DOI: 10.1177/09691413221117685.

References

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Cheng X, Onaitis M, DAmico T, Chen H . Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery. Ann Surg. 2017; 267(1):37-38. DOI: 10.1097/SLA.0000000000002405. View

Chen H, Yu S, Ho B, Su K, Hsu Y, Chang C . R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability. J Clin Oncol. 2015; 33(20):2303-10. DOI: 10.1200/JCO.2014.59.3590. View

DAFF M, DOLL R, Kennaway E . Cancer of the lung in relation to tobacco. Br J Cancer. 1951; 5(1):1-20. PMC: 2007759. DOI: 10.1038/bjc.1951.1. View

Guo Y, Zeng H, Zheng R, Li S, Barnett A, Zhang S . The association between lung cancer incidence and ambient air pollution in China: A spatiotemporal analysis. Environ Res. 2015; 144(Pt A):60-65. DOI: 10.1016/j.envres.2015.11.004. View

Bell D, Gore I, Okimoto R, Godin-Heymann N, Sordella R, Mulloy R . Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet. 2005; 37(12):1315-6. DOI: 10.1038/ng1671. View

de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View

Oken M, Hocking W, Kvale P, Andriole G, Buys S, Church T . Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011; 306(17):1865-73. DOI: 10.1001/jama.2011.1591. View

Henschke C, Yankelevitz D, Libby D, Pasmantier M, Smith J, Miettinen O . Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355(17):1763-71. DOI: 10.1056/NEJMoa060476. View

10.

Luo X, Zheng S, Liu Q, Wang S, Li Y, Shen L . Should Nonsmokers Be Excluded from Early Lung Cancer Screening with Low-Dose Spiral Computed Tomography? Community-Based Practice in Shanghai. Transl Oncol. 2017; 10(4):485-490. PMC: 5432682. DOI: 10.1016/j.tranon.2017.02.002. View

11.

Ohtsuka K, Ohnishi H, Kurai D, Matsushima S, Morishita Y, Shinonaga M . Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation. J Clin Oncol. 2010; 29(8):e191-2. DOI: 10.1200/JCO.2010.31.4492. View

12.

Yamamoto H, Higasa K, Sakaguchi M, Shien K, Soh J, Ichimura K . Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. J Natl Cancer Inst. 2013; 106(1):djt338. PMC: 3906987. DOI: 10.1093/jnci/djt338. View

13.

Hsiung C, Lan Q, Hong Y, Chen C, Hosgood H, Chang I . The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010; 6(8). PMC: 2916850. DOI: 10.1371/journal.pgen.1001051. View

14.

Zhang Y, Zhang Y, Chen S, Li Y, Yu Y, Sun Y . Is bronchoscopy necessary in the preoperative workup of a solitary pulmonary nodule?. J Thorac Cardiovasc Surg. 2015; 150(1):36-40. DOI: 10.1016/j.jtcvs.2015.02.060. View

15.

Donington J . An Additional Step Toward Personalization of Surgical Care for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2015; 34(4):295-6. DOI: 10.1200/JCO.2015.64.7578. View

16.

Zhuge L, Huang Y, Wang S, Xie J, Huang B, Zheng D . Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational?. J Cancer Res Clin Oncol. 2018; 145(2):503-509. PMC: 6373267. DOI: 10.1007/s00432-018-2814-2. View

17.

Church T, Black W, Aberle D, Berg C, Clingan K, Duan F . Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013; 368(21):1980-91. PMC: 3762603. DOI: 10.1056/NEJMoa1209120. View

18.

Liang F, Wu C, Gu H, Zhu M, Xuan Z, Jiang Y . Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening. Lung Cancer. 2019; 132:114-118. DOI: 10.1016/j.lungcan.2019.04.020. View

19.

Postmus P, Kerr K, Oudkerk M, Senan S, Waller D, Vansteenkiste J . Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28(suppl_4):iv1-iv21. DOI: 10.1093/annonc/mdx222. View

20.

Fu J, Jiang D, Lin G, Liu K, Wang Q . An ecological analysis of PM2.5 concentrations and lung cancer mortality rates in China. BMJ Open. 2015; 5(11):e009452. PMC: 4663405. DOI: 10.1136/bmjopen-2015-009452. View